Bacterial Pneumonia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Nabriva Therapeutics Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial of Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia
DUBLIN, Ireland and KING OF PRUSSIA, Pa., May 21, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV) today announced positive topline results from its Lefamulin Evaluation Against Pneumonia (LEAP 2) clinical trial, the second of two... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - May 21, 2018 Category: Pharmaceuticals Source Type: clinical trials

Epidemiology of Post-influenza Bacterial Pneumonia Due to a Panton-Valentine Leukocidin Positive Staphylococcus Aureus
Conditions: Influenza; Staphylococcus Aureus Pneumonia; PV Leukocidin Intervention: Sponsor: Central Hospital, Nancy, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2017 Category: Research Source Type: clinical trials